• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2A 型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症

Primary hyperparathyroidism in multiple endocrine neoplasia type 2A.

作者信息

Raue F, Kraimps J L, Dralle H, Cougard P, Proye C, Frilling A, Limbert E, Llenas L F, Niederle B

机构信息

Medizinische Universitätsklinik, Heidelberg, Germany.

出版信息

J Intern Med. 1995 Oct;238(4):369-73. doi: 10.1111/j.1365-2796.1995.tb01212.x.

DOI:10.1111/j.1365-2796.1995.tb01212.x
PMID:7595174
Abstract

The rarity of primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia type 2A (MEN 2A) led us to study clinical findings, surgical therapy and outcome in 67 patients in order to evaluate our therapeutic strategy. The retrospective study was based on cases registered by the EUROMEN study group (nine participating centres) from 1972 to 1993. Characteristics of PHPT in 67 patients (41 females, 26 males) with MEN 2A were reviewed. All patients underwent exploratory neck surgery; PHPT was confirmed histologically and/or biochemically. The median age at diagnosis of PHPT was 38 years. In 75% of the patients, PHPT and medullary thyroid carcinoma were diagnosed synchronously, while in 4%. PHT was diagnosed earlier. In 18% of the patients, PHPT was diagnosed after thyroidectomy, and in 3%, after discovery of pheochromocytoma. Primary hyperparathyroidism was asymptomatic in 84% of the patients; 15% suffered from renal stones. Serum calcium was slightly elevated in 69% (2.9 +/- 0.2 mmol-1) and normal in 16% of subjects. A single adenomectomy was performed in 42% of the patients, subtotal parathyroidectomy in 31% and total parathyroidectomy with autotransplantation in 16%. Independent from the extent of resection, cure was achieved in 94% of the patients, including 13% with hypoparathyroidism; hypercalcaemia persisted in 3% and no information was available in 3%. In an 8-year follow-up, hypercalcaemia recurred in 12% of the patients, although half had undergone parathyroidectomy totally or subtotally. CONCLUSION. MEN 2A-related PHPT is characterized by a mild hypercalcemia which is mostly asymptomatic and can be cured by simple resection of an enlarged parathyroid gland in most cases.

摘要

2A 型多发性内分泌腺瘤病(MEN 2A)中原发性甲状旁腺功能亢进症(PHPT)较为罕见,这促使我们对 67 例患者的临床症状、手术治疗及预后进行研究,以评估我们的治疗策略。这项回顾性研究基于欧洲 MEN 研究小组(9 个参与中心)1972 年至 1993 年登记的病例。我们回顾了 67 例(41 例女性,26 例男性)患有 MEN 2A 的 PHPT 患者的特征。所有患者均接受了颈部探查手术;PHPT 通过组织学和/或生化检查得以确诊。PHPT 确诊时的中位年龄为 38 岁。75%的患者中,PHPT 和甲状腺髓样癌同时被诊断出来,而 4%的患者中,PHPT 被更早诊断。18%的患者在甲状腺切除术后被诊断出 PHPT,3%的患者在发现嗜铬细胞瘤后被诊断出。84%的患者原发性甲状旁腺功能亢进症无症状;15%的患者患有肾结石。69%的受试者血清钙轻度升高(2.9±0.2 mmol/L),16%的受试者血清钙正常。42%的患者进行了单个腺瘤切除术,31%的患者进行了甲状旁腺次全切除术,16%的患者进行了甲状旁腺全切除术并自体移植。无论切除范围如何,94%的患者治愈,其中 13%患有甲状旁腺功能减退症;3%的患者高钙血症持续存在,3%的患者无相关信息。在 8 年的随访中,12%的患者高钙血症复发,尽管其中一半患者已接受了甲状旁腺全切除或次全切除术。结论:MEN 2A 相关的 PHPT 的特点是轻度高钙血症,大多无症状,多数情况下通过简单切除增大的甲状旁腺即可治愈。

相似文献

1
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A.2A 型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症
J Intern Med. 1995 Oct;238(4):369-73. doi: 10.1111/j.1365-2796.1995.tb01212.x.
2
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.IIa型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症:法国多中心回顾性研究。降钙素肿瘤研究组(GETC,法国降钙素肿瘤研究组),法国内分泌外科医生协会。
World J Surg. 1996 Sep;20(7):808-12; discussion 812-3. doi: 10.1007/s002689900123.
3
Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.2A 型多发性内分泌腺瘤病患者甲状旁腺功能亢进的外科治疗
Surgery. 1996 Dec;120(6):966-73; discussion 973-4. doi: 10.1016/s0039-6060(96)80042-0.
4
Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.2A 型多发性内分泌肿瘤患者原发性甲状旁腺功能亢进症的手术治疗演变。
Endocr Pract. 2011 Jan-Feb;17(1):7-15. doi: 10.4158/EP10050.OR.
5
Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2.
Surgery. 1993 Dec;114(6):1031-7; discussion 1037-9.
6
Surgical management of MEN-1 and -2: state of the art.MEN-1和MEN-2的外科治疗:最新进展
Surg Clin North Am. 2009 Oct;89(5):1047-68. doi: 10.1016/j.suc.2009.06.016.
7
[Bilateral neck exploration with intraoperative iPTH assay in patients not eligible for minimally invasive parathyroidectomy].[对不符合微创甲状旁腺切除术条件的患者进行双侧颈部探查并术中检测甲状旁腺激素]
Przegl Lek. 2014;71(2):66-71.
8
Clinical profile of primary hyperparathyroidism in adolescents and young adults.青少年和青年原发性甲状旁腺功能亢进症的临床特征
Clin Endocrinol (Oxf). 1998 Apr;48(4):435-43. doi: 10.1046/j.1365-2265.1998.00329.x.
9
Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.散发性与 MEN 相关原发性甲状旁腺功能亢进症的区别;临床表现、术前检查、手术策略和随访。
Orphanet J Rare Dis. 2013 Apr 1;8:50. doi: 10.1186/1750-1172-8-50.
10
Surgical approaches in hereditary endocrine tumors.遗传性内分泌肿瘤的手术治疗方法
Updates Surg. 2017 Jun;69(2):181-191. doi: 10.1007/s13304-017-0451-y. Epub 2017 Apr 28.

引用本文的文献

1
MEN2: surgical precision in the era of precision medicine.MEN2:精准医学时代的手术精准性。
Endocr Relat Cancer. 2025 Jun 6;32(6). doi: 10.1530/ERC-24-0251. Print 2025 Jun 1.
2
Impact of concurrent parathyroid adenoma on the recurrence of differentiated thyroid carcinoma: a retrospective study.甲状旁腺腺瘤并发对分化型甲状腺癌复发的影响:一项回顾性研究。
Turk J Med Sci. 2024 Dec 9;55(1):96-102. doi: 10.55730/1300-0144.5947. eCollection 2025.
3
Primary Hyperparathyroidism in MEN2 Syndromes.MEN2综合征中的原发性甲状旁腺功能亢进症。
Recent Results Cancer Res. 2025;223:237-246. doi: 10.1007/978-3-031-80396-3_9.
4
Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.遗传性甲状腺髓样癌:基因型与表型的相关性
Recent Results Cancer Res. 2025;223:183-209. doi: 10.1007/978-3-031-80396-3_7.
5
Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.甲状腺髓样癌的流行病学、临床表现及诊断
Recent Results Cancer Res. 2025;223:93-127. doi: 10.1007/978-3-031-80396-3_4.
6
Heritable hyperparathyroidism: Genetic insights and clinical implications.遗传性甲状旁腺功能亢进症:遗传学见解与临床意义。
Best Pract Res Clin Endocrinol Metab. 2025 Mar;39(2):101984. doi: 10.1016/j.beem.2025.101984. Epub 2025 Mar 1.
7
Familial states of primary hyperparathyroidism: an update.家族性原发性甲状旁腺功能亢进症:最新进展。
J Endocrinol Invest. 2024 Sep;47(9):2157-2176. doi: 10.1007/s40618-024-02366-7. Epub 2024 Apr 18.
8
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?2型多发性内分泌腺瘤病患者的基因型特异性表型是否如现行指南所预测的那样出现?
Cancers (Basel). 2024 Jan 24;16(3):494. doi: 10.3390/cancers16030494.
9
Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue.自体移植组织中的远程复发性原发性甲状旁腺功能亢进症。
Cureus. 2023 Jun 21;15(6):e40715. doi: 10.7759/cureus.40715. eCollection 2023 Jun.
10
[Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].[遗传性原发性甲状旁腺功能亢进症的诊断与治疗特点]
Chirurgie (Heidelb). 2023 Jul;94(7):586-594. doi: 10.1007/s00104-023-01897-8. Epub 2023 Jun 8.